Elan and Biogen Suspend Marketeing of TYSABRI
Elan and Biogen Idec's ongoing safety evaluation of TYSABRI has led to a previously diagnosed case of malignant astrocytoma being…
network
Elan and Biogen Idec's ongoing safety evaluation of TYSABRI has led to a previously diagnosed case of malignant astrocytoma being…